CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
CollPlant Biotechnologies Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$3.56−0.06 (-1.79%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns CollPlant Biotechnologies's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| The Loewenbaum 1992 Trust | 3,597,047 | 17.50% | 13D (active) amendment | Aug 19, 2026 |
| Ami Sagy | 163,709 | 5.70% | 13D (active) amendment | Sep 30, 2026 |
| George Walter Loewenbaum | 1,256,056 | 9.90% | 13D (active) amendment | Nov 6, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yehiel Tal | Chief Executive Officer, Director | 31,137 | 0.24% | Mar 19, 2026 |
| Bar Berta Abelis | VP Legal | 206,441 | 1.61% | Sep 8, 2026 |
| Eran Rotem | Deputy CEO and CFO | 516,372 | 4.03% | Sep 8, 2026 |
| Bowman Bagley | VP Commercial North America | 25,000 | 0.20% | Mar 18, 2026 |
| Jasmine Seror | VP Product Development | 45,000 | 0.35% | Mar 18, 2026 |
| Philippe Bensimon | VP Regulations and QA | 2,000 | 0.02% | Mar 18, 2026 |
| Oren Fahimipoor | VP Operations | 30,000 | 0.23% | Mar 18, 2026 |
| Hugh M. Evans | Director | 325,554 | 2.54% | Apr 27, 2026 |
| Elan Penn | Director | 7,500 | 0.06% | Mar 18, 2026 |
| Alisa Lask | Director | 10,000 | 0.08% | Mar 18, 2026 |
| Avraham Havron | Director | 10,000 | 0.08% | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Bar Berta Abelis VP Legal | Sep 3, 2026 | Award | +201,141 | – | – | 206,441 |
| Eran Rotem Deputy CEO and CFO | Sep 3, 2026 | Award | +510,372 | – | – | 516,372 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sagy Ami Shareholder | Oct 9, 2025 | 140,000 | $308.00K | Oct 10, 2025 | Private placement from Issuer |
| Sagy Ami Shareholder | Sep 22, 2023 | 56,098 | $336.59K | Sep 21, 2023 | Ami Sagy |
| Sagy Ami Shareholder | Sep 12, 2023 | 87,853 | $633.42K | Sep 12, 2023 | Ami Sagy |
| Ami Sagy 10% Stockholder | Jun 14, 2023 | 110,000 | $798.60K | Jun 14, 2023 | Private Placement |